Nuveen Small Cap Growth Opp C (FMPCX)
11.13
+0.03 (+0.27%)
USD |
May 20 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.96% | 177.40M | 0.00% | 97.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -14.57M | -24.95% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks growth of capital. Under normal market conditions, the fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in common stocks of small-capitalization companies. Small-capitalization companies are defined as companies that have market capitalizations within the market capitalization range of the companies in the Russell 2000® Index on the last business day of the month in which its most recent reconstitution was completed. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FIMPX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Nuveen |
| Prospectus Benchmark Index | |
| Russell 2000 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Jon Loth | 14.51 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
42
-14.57M
-2.609B
Category Low
1.147B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 20, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 20, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Matador Resources Co | 2.27% | 50.39 | 0.94% |
| Silicon Laboratories Inc | 2.22% | 140.45 | 0.80% |
| Lattice Semiconductor Corp | 2.09% | 49.92 | 1.24% |
| II-VI Inc | 2.07% | 59.08 | 0.70% |
| MACOM Technology Solutions Holdings Inc | 1.95% | 52.51 | -0.47% |
| Tetra Tech Inc | 1.93% | 124.78 | -1.05% |
| HealthEquity Inc | 1.87% | 59.23 | 0.37% |
| Pacira BioSciences Inc | 1.86% | 63.59 | 0.87% |
| Ensign Group Inc | 1.86% | 79.03 | 0.13% |
| ASGN Inc | 1.84% | 97.96 | -0.33% |
Basic Info
| Investment Strategy | |
| The investment seeks growth of capital. Under normal market conditions, the fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in common stocks of small-capitalization companies. Small-capitalization companies are defined as companies that have market capitalizations within the market capitalization range of the companies in the Russell 2000® Index on the last business day of the month in which its most recent reconstitution was completed. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FIMPX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Nuveen |
| Prospectus Benchmark Index | |
| Russell 2000 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Jon Loth | 14.51 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-20-22) | 0.00% |
| 30-Day SEC Yield (7-31-20) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 22.08 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 9/24/2001 |
| Last Annual Report Date | 10/31/2021 |
| Last Prospectus Date | 2/28/2022 |
| Share Classes | |
| FIMPX | Inst |
| FMPFX | Retirement |
| FRMPX | A |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |